20 / 2017-11-13 22:29:56
Targeted treatment of ischemia-reperfusion injury in abdominal flaps of rats by magnetic alprostadil lipid microsphere
Alprostadil lipid microsphere, Magnetic targeted treatment, Ischemia-reperfusion injury
全文待审
ukelin Zho / fuyl biomedical
Objective To investigate the effects of magnetic alprostadil lipid microsphere in targeted treatment of ischemia-reperfusion injury in abdominal flaps of rats. Methods An animal model of ischemia-reperfusion injury in abdominal flaps of rats was developed. The study group was injected with magnetic alprostadil lipid microsphere via the opposite femoral artery, while the control group injected with physiological saline, and the blank group was treated with no vessel blockage or medication after skin flap preparation. At different time points of ischemia and reperfusion of the skin flaps, the blood flow volume and the content of MDA and NO in the flap tissues were determined by a laser Doppler Flowmetry, thiobarbituric acid method, and nitrate reductase method, respectively. At 7d after suture in situ of the skin flaps, the designed area and survived area of the skin flaps were determined by coordinate decal method, based on which, the survival rate of the skin flaps was calculated. Meanwhile, routine histopathologic slides of the flap tissues were taken for immunohistochemical staining to identify the expression of vascular endothelial growth factor (VEGF). Results The study group had significantly higher micro-circulation volume, NO synthesis quantity, VEGF expression density, and 7-d survival rate and significantly lower MDS level of the skin flaps than the control group and blank group. Conclusion As a high-performance bioactive compound, alprostadil can improve the micro-circulation and lighten the ischemia-reperfusion injury by increasing NO content and protecting the vascular endothelium of skin flaps.
重要日期
  • 会议日期

    12月13日

    2017

    12月20日

    2018

  • 10月10日 2018

    摘要截稿日期

  • 10月20日 2018

    摘要录用通知日期

  • 10月25日 2018

    初稿截稿日期

  • 11月08日 2018

    初稿录用通知日期

  • 11月28日 2018

    终稿截稿日期

  • 12月20日 2018

    注册截止日期

主办单位
DMIC
联系方式
移动端
在手机上打开
小程序
打开微信小程序
客服
扫码或点此咨询